Ferritin and haemosiderin were shown, by the measurement of malondialdehyde production and loss of polyunsaturated fatty acids, to stimulate lipid peroxidation in liposomes. At pH7.4 ascorbate was additionally required to achieve peroxidation; however, peroxidation occurred at pH4.5 in the presence of iron-proteins alone. The damage was completely inhibited by the incorporation of chain-breaking antioxidants (a-tocopherol and butylated hydroxytoluene) into the liposomes. Metal chelators (desferrioxamine and EDTA) also completely inhibited lipid peroxidation. These and further results indicate that, at pH4.5, even in the absence of a reducing agent, iron is released from haemosiderin and can mediate oxidative damage to a lipid membrane.
Iron overload is well recognized to cause damage to the liver and other organs. Ferritin has been shown to be the major iron-protein in normal liver; however, in iron overload haemosiderin is predominant (Selden et al., 1980) . Haemosiderin is thought to accumulate in lysosomes, and a close positive correleation has been shown between enhanced lysosomal fragility and haemosiderin content of the tissue (Seymour & Peters, 1979) . It has been suggested that the toxicity of iron could be mediated by haemosiderin dependent damage to the lysosomal membrane, possibly by a lipidperoxidation mechanism (Selden et al., 1980) . Ferritin has been reported to stimulate the peroxidation of lipids, at pH 7.4, in the presence of ascorbate (Wills, 1966) , and also to a limited extent in the absence of ascorbate (Gutteridge et al., 1983) . In the present paper we present detailed comparisons of the ability of ferritin and haemosiderin to stimulate lipid peroxidation in a model membrane both at pH 7.4 and at pH 4.5. The latter is considered to be a model for intralysosomal conditions.
Materials and methods
Ferritin from horse spleen, phosphatidylcholine (99% pure, in chloroform) from egg yolk, at To whom reprint requests should be addressed.
tocopherol from vegetable oil and butylated hydroxytoluene were supplied by Sigma. All other chemicals were of AnalaR grade and supplied by BDH Chemicals.
Human haemosiderin (Weir et al., 1984) and ferritin (Huebers et al., 1974) were isolated from iron-overloaded thalassaemic human spleens. Haemosiderin was freeze-dried and stored desiccated at room temperature. On the day of use, solutions (approx. 10mM-iron) were prepared in 20mM-tetramethylammonium hydroxide solution (Weir et al., 1984) .
Small unilamellar liposomes were prepared essentially by the method of Gregoriadis & Ryman (1972) . Chloroform solutions of phosphatidylcholine were evaporated to dryness with a rotary evaporator to form a thin film of lipid. Where indicated, chloroform solutions of a-tocopherol or butylated hydroxytoluene were added before evaporation. The lipid was resuspended in the appropriate aqueous buffer, with the aid of a few glass beads, to a concentration of 10 or 20mg/ml. The liposomes were allowed to equilibrate and swell under an atmosphere of N2 in the dark for 1 h. The suspension was then sonicated at 20pm peak-topeak, with an MSE 150W Mk II sonicator with an exponential probe, on ice for ten periods of60 s with intervals of 30 s. Incubations were at 37°C, aerobic, continuously shaken, and in 50mM-Tris/HCl buffer, pH 7.4, or 50mM-sodium acetate/acetic acid Vol. 229 buffer, pH4.5. Although haemosiderin alone, at pH4.5, will precipitate within a few minutes, a stable suspension was formed in the presence of liposomes.
Malondialdehyde was determined by reaction with thiobarbituric acid (Slater & Sawyer, 1971) . Amounts of malondialdehyde were calculated from the A535 (E 1.5 x 1051mol-Icm-l). Samples for g.l.c. analysis of fatty acid composition were extracted with 4 vol. of chloroform/methanol (2:1, v/v). Methyl esters of the fatty acids were prepared and analysed with a Pye-Unicam 204 instrument (Cairns & Peters, 1983) . Peak areas representing arachidonate, linoleate and stearate were related to that of palmitate (e.g. linoleate/palmitate). The relative peak areas in incubations containing ironproteins are reported as percentages of those in control incubations. Iron concentrations were determined with the use of a Perkin-Elmer 2380 electrothermal atomic absorption spectrophotometer.
Results
Liposomes were peroxidized (as shown by malondialdehyde increase) when incubated with human or horse ferritin and ascorbate at pH 7.4 ( Fig. 1 ). Very limited peroxidation was detected at pH 7.4 in the absence of ascorbate.
Human haemosiderin stimulated malondialdehyde increases at pH 7.4 in the presence of ascorbate ( Fig. 1 ), although to an extent approx. 8-fold less than that with ferritin at equivalent iron concentrations. No lipid peroxidation was detectable in the absence of ascorbate.
To model intralysosomal conditions, where haemosiderin accumulates in vivo, horse spleen ferritin and human haemosiderin were incubated with liposomes at pH4.5. At this pH both ironproteins stimulated malondialdehyde increase without the addition of ascorbate (Fig. 2) . Again the extent of peroxidation was greater with ferritin than with haemosiderin at equivalent iron concentrations.
Membrane lipid peroxidation was confirmed by the determination of changes in fatty acid composition (Fig. 3) . In all cases where malondialdehyde increase had been detected, the amounts of arachidonate and linoleate decreased relative to those in control experiments. Again changes were found at pH 7.4 in the presence of ferritin (Fig. 3a) or haemosiderin ( Fig. 3b) and ascorbate (but not in the presence of either iron-protein or ascorbate alone) and at pH 4.5 in the presence of ferritin (Fig.  3c) or haemosiderin (Fig. 3d) therefore centred on this system. The malondialdehyde increase caused by 500Mm-(Fe) haemosiderin t pH4.5, to at pH4.5 could be completely inhibited by the tbsence of a incorporation of a-tocopherol or butylated tat this ironhydroxytoluene into the liposome membrane. The in lysosomal a-tocopherol content of mammalian membranes is ue. Further approx. 0.5mmol/mol of lipid (Gruger & Tappel, damage was 1971) , and this value was found to give partial protection (17%) of the liposomes. Butylated hydroxytoluene at 0.5mmol/mol of lipid gave 63% inhibition of lipid peroxidation, and at lOmmol/ mol of lipid the inhibition was 94% and 92% for the two antioxidants respectively. The malondialdehyde formed with 500 pM-(Fe) haemosiderin at pH4.5 was completely inhibited by 50 pM-desferrioxamine and partially inhibited by concentrations as low as 5 gm (Fig. 4) Fe) ferritin pellet the residual haemosiderin. Iron was detected lOOpM- (Fe) in the supernatant ( incubation of haemosiderin in pH4.5 incubated with liposomes, it was foul late malondialdehyde production comj that in the presence of 500 pM-(Fe) ha Discussion Ferritin and haemosiderin at pH very little stimulation of lipid peroxid phosphatidylcholine liposomes, in the ascorbate. Previous work (Gutteridge et al., 1983) has shown that ferritin-dependent peroxidation, with bovine brain phospholipid liposomes, occurs to a relatively limited extent at pH 7.4 in the absence of ascorbate. The iron cores within ferritin and haemosiderin may not therefore be expected to cause extensive direct damage to cytoplasmic membranes. This is supported by the finding that, where extensive lipid peroxidation did occur, it could be completely inhibited by metal-ion chelators. Both iron-proteins were found to stimulate 3 4 peroxidation at pH 7.4, in the presence of ascorbate. This agrees with previous work (Wills, 1966; siderin-stimuGutteridge et al., 1983; O'Connell et al., 1985) .
Under these conditions iron would be expected to on incubabe mobilized as an Fe2+-ascorbate complex (Siriuffer, in the vech et al., 1974) , and lipid peroxidation could be n and the induced by oxygen radicals generated in Fe2+-itions; (0) dependent Fenton-type reactions (Halliwell, 1976 ). ) 5OumM-There is evidence that ascorbate is involved in the v standard mobilization of storage iron in vivo (Lipschitz et al., 1971; Roeser et al., 1983) . Furthermore the administration of ascorbic acid to patients with iron-overload has proved toxic unless given in conjunction with desferrioxamine (Propper & Nathan, 1977) .
At pH 4.5, lipid peroxidation stimulated by ferritin and haemosiderin in the absence of any reducing agent must be mediated by ferric iron. The nature of the iron that is released from haemosiderin into acetate buffer is unclear, but monomeric ferric acetate and oligomeric ferric oxide seem to be two possibilities. Ferric ions in solution have been shown to stimulate lipid peroxidation by catalysing the decomposition of pre-existing lipid hydroperoxide to lipid peroxyl radicals (O'Brien, 1969; O'Connell & Garner, 1983 The finding that ferritin is more effective than haemosiderin in stimulating lipid peroxidation suggests that the conversion of ferritin into haemo-5 buffer was siderin that occurs in iron-overload (Selden et al., nd to stimu-1980) may be a mechanism for cytoprotection parable with against iron toxicity. This difference between iemosiderin.
ferritin and haemosiderin may be due to differences in the rate at which iron can be mobilized from the two iron-proteins. We have found that at pH7.4 iron is released from ferritin to 1,10-7.4 showed phenanthroline (method of Hoy et al., 1973) at lation in egg more than double the rate of release from e absence of haemosiderin. In iron-overload syndromes the quantity of haemosiderin deposited is such that even a relatively slow rate of iron release in vivo may be important in iron toxicity. Certainly iron release would be favoured by the acidic intralysosomal conditions, and this could lead to membrane lipid peroxidation. Indeed, lysosomes have been shown to be disrupted by free-radicalmediated lipid peroxidation in vitro (Fong et al., 1973) . Further studies are required to determine whether similar effects can be demonstrated in lysosomes in vivo in experimental iron overload.
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